Skip to main navigation Skip to main content
Home
Consumer Healthcare Products Association
Taking healthcare personally.

User account menu

  • About CHPA
  • Membership
  • CHPA Educational Foundation
  • Career Center
  • Login
  • Our Issues
      1. OTC Medicines
        1. Acetaminophen
        2. Children's Cough and Cold Medicines
        3. DXM (dextromethorphan)
        4. Monograph Reform
        5. Pediatrics Medicine
        6. PSE (Pseudoephedrine)
        7. RX-to-OTC Switch
        8. Sunscreen
      2. Dietary Supplements
        1. CBD and Hemp Oil
        2. DSHEA
        3. Immunity
        4. New Dietary Ingredients
        5. Probiotics
        6. Vitamins and Minerals
      3. Consumer Medical Devices
        1. 510(K) Modifications
        2. Device Classification
      4. Other Issues
        1. Branding
        2. COVID-19
        3. FSA/HSA
        4. Ingredient Safety
        5. Labeling
        6. Packaging
        7. Proposition 65
        8. Quality
        9. Research
        10. Safe Storage
        11. Sales Tax Exemption
        12. Sustainable Chemistry
  • Public Policy & Regulatory
      1. Regulation
        1. Regulation of OTC Medicines
        2. Regulation of Dietary Supplements
        3. Regulation of Consumer Medical Devices
        4. Submissions
      2. Voluntary Codes and Guidelines
      3. Legislative Priorities
        1. Federal Legislative Priorities
        2. State & Local Legislative Priorities
  • Events & Education
      1. Annual Self-Care Leadership Series & Summit
      2. CHPA Academy
      3. Regulatory, Scientific & Quality Conference
      4. CHPA Educational Foundation Gala
      5. Become A Sponsor
  • About Consumer Healthcare
      1. Research & Data
        1. OTC Use Statistics
        2. Consumer Medical Device Statistics
        3. Research Reports
      2. Consumer Information
        1. Infographics
        2. Videos
      3. Activities & Initiatives
        1. Preventing Dextromethorphan Abuse
        2. Preventing Illegal Meth Production
        3. Safe Use of Acetaminphen
        4. Tax Free OTC
        5. The Value of OTC Medicines
      4. FAQs
  • News
Open Search
Open Menu

Main navigation

  • Our Issues
    • OTC Medicines
      • Acetaminophen
      • Children's Cough and Cold Medicines
      • DXM (dextromethorphan)
      • Monograph Reform
        • User Fees
      • Pediatrics Medicine
      • PSE (Pseudoephedrine)
      • RX-to-OTC Switch
      • Sunscreen
    • Dietary Supplements
      • CBD and Hemp Oil
      • DSHEA
      • Immunity
      • New Dietary Ingredients
      • Probiotics
      • Vitamins and Minerals
    • Consumer Medical Devices
      • 510(K) Modifications
      • Device Classification
    • Other Issues
      • Branding
      • COVID-19
      • FSA/HSA
      • Ingredient Safety
      • Labeling
      • Packaging
      • Proposition 65
      • Quality
      • Research
      • Safe Storage
      • Sales Tax Exemption
      • Sustainable Chemistry
  • Public Policy & Regulatory
    • Regulation
      • Regulation of OTC Medicines
        • Child-Resistant Packaging
        • Drug Distribution and National Uniformity
        • OTC Drug Advertising
        • Structured Product Labeling
      • Regulation of Dietary Supplements
        • Dietary Supplement Safety
        • Labeling Dietary Supplements
        • Marketing and Advertising Dietary Supplements
      • Regulation of Consumer Medical Devices
      • Submissions
    • Voluntary Codes and Guidelines
    • Legislative Priorities
      • Federal Legislative Priorities
      • State & Local Legislative Priorities
  • Events & Education
    • Annual Self-Care Leadership Series & Summit
    • CHPA Academy
    • Regulatory, Scientific & Quality Conference
    • CHPA Educational Foundation Gala
    • Become A Sponsor
  • About Consumer Healthcare
    • Research & Data
      • OTC Use Statistics
      • Consumer Medical Device Statistics
      • Research Reports
    • Consumer Information
      • Infographics
      • Videos
    • Activities & Initiatives
      • Preventing Dextromethorphan Abuse
      • Preventing Illegal Meth Production
      • Safe Use of Acetaminphen
      • Tax Free OTC
      • The Value of OTC Medicines
    • FAQs
  • News

User account menu

  • About CHPA
  • Membership
  • CHPA Educational Foundation
  • Career Center
  • Login
  • LinkedIn
  • YouTube
  • Twitter
  • Facebook

Breadcrumb

  1. Home
  2. Public Policy & Regulatory
  3. Regulation
  4. Submissions
  5. Side-by-Side Comparison: 21 CFR, Parts 110, 111, 211 and 820

Side-by-Side Comparison: 21 CFR, Parts 110, 111, 211 and 820

Share page:

White Paper | Mar 4, 2015

Download Document
Issues:
OTC Medicines

Related Posts

Orange CHPA logo on dark blue background

Press Releases and Statements

CHPA Welcomes Three Consumer Healthcare Industry Members

Feb 22, 2021

blue coronavirus particles on dark background

Press Releases and Statements

CHPA Statement: OTC Pain Relievers and COVID-19 Vaccines

Feb 4, 2021

three edison lightbulbs on a dark blue background

Research Reports

Insights with Impact: Women's Health and OTC Birth Control

Jan 8, 2021

Consumer Healthcare Products Association | Taking healthcare personally.

  • LinkedIn
  • YouTube
  • Twitter
  • Facebook

Consumer Healthcare Products Association
1625 Eye Street, NW, Suite 600
Washington, DC 20006
T: 202.429.9260
F: 202.223.6835

About Us

  • Career Center
  • Contact Us
  • Our Members
  • Our Team

Quick Links

  • KnowYourOTCs
  • Know Your Dose
  • Up and Away
  • Annual Report

© 2021 Consumer Healthcare Products Association - CHPA. All Rights Reserved

Footer

  • Privacy Policy
  • Terms of Use
  • Sitemap